A #MarchforScience participant talks about the need to stand up to anti-science policies, rhetoric
Without strong support for the sciences, our quest to transform basic research into meaningful new medicines will wither and die.
Emma Walmsley makes history as Big Pharma’s first female CEO
On Friday, GlaxoSmithKline's CEO of eight years, Andrew Witty, will formally retire and take a sliver of the proverbial glass ceiling with him. His replacement, Emma Walmsley, will be the first female head of a Big Pharma company.
presented by
Closing the Quality-Affordability Gap in Workplace Mental Health
In an interview, Kyan Health Co-Founder and Chief Commercial Officer Konstantin Struck discussed how Kyan gives mid-market and enterprise employers access to premium workforce mental healthcare, at a price point that is affordable.
Two new venture funds, two new women at the top
Welcome to the senior VC club. Julie Sunderland of Biomatics Capital and Tracy Saxton of Pivotal bioVenture Partners closed their first funds this week, bringing fresh perspectives to the life science investment game.
Study: Women hold just 1/10 biotech board seats
Not surprising, but still dismal: A new Liftstream study of 177 publicly-listed biotechs found just 10.9 percent of board seats are occupied by women and just 8 percent had a female CEO.